93 related articles for article (PubMed ID: 23546309)
21. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
[TBL] [Abstract][Full Text] [Related]
23. The cytoplasmic C-terminal domain but not the N-terminal domain of latent membrane protein 1 of Epstein-Barr virus is essential for B cell activation.
Peng-Pilon M; Ruuth K; Lundgren E; Brodin P
J Gen Virol; 1995 Apr; 76 ( Pt 4)():767-77. PubMed ID: 9049322
[TBL] [Abstract][Full Text] [Related]
24. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.
D'Souza B; Rowe M; Walls D
J Virol; 2000 Jul; 74(14):6652-8. PubMed ID: 10864681
[TBL] [Abstract][Full Text] [Related]
25. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.
Zuo L; Yu H; Liu L; Tang Y; Wu H; Yang J; Zhu M; Du S; Zhao L; Cao L; Li G; Lu J
Oncotarget; 2015 Dec; 6(38):41033-44. PubMed ID: 26517512
[TBL] [Abstract][Full Text] [Related]
26. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of activating transcription factor-5 suppresses SAP expression to activate T cells in hemophagocytic syndrome associated with Epstein-Barr virus infection and immune disorders.
Chuang HC; Wang JM; Hsieh WC; Chang Y; Su IJ
Am J Pathol; 2008 Nov; 173(5):1397-405. PubMed ID: 18832568
[TBL] [Abstract][Full Text] [Related]
30. Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis.
Coffin WF; Geiger TR; Martin JM
J Virol; 2003 Mar; 77(6):3749-58. PubMed ID: 12610149
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
[TBL] [Abstract][Full Text] [Related]
32. Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-kappaB activity.
Bloss T; Kaykas A; Sugden B
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3227-3232. PubMed ID: 10567655
[TBL] [Abstract][Full Text] [Related]
33. Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling.
Shimabuku T; Tamanaha A; Kitamura B; Tanabe Y; Tawata N; Ikehara F; Arakaki K; Kinjo T
Int J Clin Exp Pathol; 2014; 7(5):1920-34. PubMed ID: 24966902
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma.
Kim JH; Kim WS; Park C
Leuk Lymphoma; 2013 Sep; 54(9):2035-40. PubMed ID: 23363221
[TBL] [Abstract][Full Text] [Related]
35. LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling.
Kaykas A; Worringer K; Sugden B
J Virol; 2002 Nov; 76(22):11551-60. PubMed ID: 12388716
[TBL] [Abstract][Full Text] [Related]
36. The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling.
Erickson KD; Martin JM
J Virol; 2000 Jan; 74(2):1057-60. PubMed ID: 10623774
[TBL] [Abstract][Full Text] [Related]
37. The LMP1 promoter can be transactivated directly by NF-kappaB.
Demetriades C; Mosialos G
J Virol; 2009 May; 83(10):5269-77. PubMed ID: 19279104
[TBL] [Abstract][Full Text] [Related]
38. Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1.
Yoshizaki T
Histol Histopathol; 2002; 17(3):845-50. PubMed ID: 12168795
[TBL] [Abstract][Full Text] [Related]
39. LMP-1 induces survivin expression to inhibit cell apoptosis through the NF-κB and PI3K/Akt signaling pathways in nasal NK/T-cell lymphoma.
Sun L; Zhao Y; Shi H; Ma C; Wei L
Oncol Rep; 2015 May; 33(5):2253-60. PubMed ID: 25760809
[TBL] [Abstract][Full Text] [Related]
40. Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression.
Johansson P; Jansson A; Rüetschi U; Rymo L
J Virol; 2009 Feb; 83(3):1393-401. PubMed ID: 19019967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
